Niger vs United Arab Emirates: Prevalence rate of hypertension in adults aged 30-79
Niger
41.5
in 2019
United Arab Emirates
41.4
in 2019
Niger rank
62nd
United Arab Emirates rank
63rd
Prevalence rate of hypertension in adults aged 30-79 over time
- Niger
- United Arab Emirates
How they compare
Niger currently reports 41.5 against 41.4 in United Arab Emirates, a difference of 0.1.
Across all 30 years both countries report, Niger has been ahead every year.
Niger ranks 62nd and United Arab Emirates ranks 63rd of 194 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Niger | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 41.1 | 37.15 | 3.95 | Niger |
| 2000s | 43.34 | 38.3 | 5.04 | Niger |
| 2010s | 42.71 | 40.24 | 2.47 | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Niger or United Arab Emirates?
- Niger, at 41.5 against 41.4 in United Arab Emirates as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Niger and United Arab Emirates?
- 0.1, with Niger ahead.
- How many years of comparable data are there for Niger and United Arab Emirates?
- 30 years are reported by both, from 1990 to 2019.
- How do Niger and United Arab Emirates rank globally for prevalence rate of hypertension in adults aged 30-79?
- Niger ranks 62nd and United Arab Emirates ranks 63rd of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.